Authors:
Wallach, S
Cohen, S
Reid, DM
Hughes, RA
Hosking, DJ
Laan, RF
Doherty, SM
Maricic, M
Rosen, C
Brown, J
Barton, I
Chines, AA
Citation: S. Wallach et al., Effects of risedronate treatment on bone density and vertebral fracture inpatients on corticosteroid therapy, CALCIF TIS, 67(4), 2000, pp. 277-285
Authors:
Orwoll, E
Ettinger, M
Weiss, S
Miller, P
Kendler, D
Graham, J
Adami, S
Weber, K
Lorenc, R
Pietschmann, P
Vandormael, K
Lombardi, A
Adachi, JD
Bell, N
Body, JJ
Castro, A
Daifotis, A
Felsenberg, D
Gilchrist, N
Hoffman, A
Maricic, M
Rizzoli, R
Silverman, S
Valeriano, J
Citation: E. Orwoll et al., Alendronate for the treatment of osteoporosis in men, N ENG J MED, 343(9), 2000, pp. 604-610
Authors:
Chesnut, CH
Silverman, S
Andriano, K
Genant, H
Gimona, A
Harris, S
Kiel, D
LeBoff, M
Maricic, M
Miller, P
Moniz, C
Peacock, M
Richardson, P
Watts, N
Baylink, D
Citation: Ch. Chesnut et al., A randomized trial of nasal spray salmon calcitonin in postmenopausal women with established osteoporosis: the prevent recurrence of osteoporotic fractures study, AM J MED, 109(4), 2000, pp. 267-276
Authors:
Maricic, M
Tesser, J
Chen, Z
Lund, P
Gluck, O
Citation: M. Maricic et al., How often does lateral spine DXA detect low bone mass in patients with both normal PA spine and hip?, J CLIN DENS, 1(3), 1998, pp. 251-257
Authors:
Chen, Z
Maricic, M
Lund, P
Tesser, J
Gluck, O
Citation: Z. Chen et al., How the new hologic hip normal reference values affect the densitometric diagnosis of osteoporosis, OSTEOPOR IN, 8(5), 1998, pp. 423-427